Manufacturer record
Janveda Healthceutical Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Janveda Healthceutical Pvt. Ltd (Gujarat) were declared Not of Standard Quality between April 2026 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: JLJ2523, Dextromethorphan Hydrobromide Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup, (exp Sep 2027). RDTL, Chandigarh (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Phenylephrine Hydrochloride. Listed in the August 2026 alert.
Records by type
3 records linked to Janveda Healthceutical Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Dextromethorphan Hydrobromide Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup, | Batch JLJ2523Mfg Oct 2025 · Exp Sep 2027 | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Phenylephrine HydrochlorideAssay | RDTL, ChandigarhCDSCO lab | Aug 2026 |
| Terbutaline Sulphate, Ambroxol Hydrochloride, Guaiphenesin & Menthol Expectorant | Batch JLI2586Mfg Sep 2025 · Exp Aug 2027 | Ambroxol Hydrochloride contentOther | FDL, VadodaraState lab | Jun 2026 |
| Deflazacort Oral Suspension | Batch JLL2526Mfg Dec 2025 · Exp Nov 2027 | The sample does not conform to claim as per Manufacture's Specification with respect to the Assay of Deflazacort.Assay | CDTL,IndoreCDSCO lab | Apr 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.